ClinicalTrials.Veeva

Menu

Sugars in Cigarettes

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Active, not recruiting

Conditions

Tobacco Use

Treatments

Other: Cigarettes with added sucrose

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05308316
2020LS236
R01DA051005 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The aim of this study is to investigate the impact of sugar levels in cigarette tobacco on cigarette abuse liability and appeal. Participants will attend several clinic visits to smoke cigarettes with different levels of sugars and will complete multiple questionnaires to assess their experiences. Each of the sessions will be separated by at least 48 hours but not more than 5 days. The hypothesis is that the measures collected in this study will indicate lower abuse liability for cigarettes with lowest sugar content.

Enrollment

30 patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female age 21 years or older
  • Smoking cigarettes that have been evaluated to have medium levels of sugar content
  • No quit attempts in the past month nor intentions to quit smoking in the next month
  • Participants are in good physical health (no unstable medical conditions) as determined by the licensed medical professional
  • Participants are in stable, good mental health (e.g. not currently, within the past 6 months, experiencing unstable or untreated psychiatric diagnosis) as determined by the licensed medical professional
  • Stable vitals sign measurements (systolic BP ≤ 160 and >90 mmHg, diastolic BP ≤ 100 and >50 mmHg and heart rate ≤105 and > 45 bpm) as determined by the licensed medical professional
  • Participants must be able to read for comprehension or completion of study documents (confirmed during informed consent process)
  • Participants have provided written informed consent to participate in the study.

Exclusion criteria

  • Significant immune system disorders, respiratory diseases, kidney or liver diseases or any other medical disorders that may affect biomarker data as determined by the licensed medical professional
  • Women who are pregnant or nursing or planning to become pregnant.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Impact of Sugar Content
Experimental group
Description:
Participants will be asked to attend 4 laboratory sessions during which they will smoke their usual brand (UB) cigarettes and then one of three study cigarettes with low, medium and high levels of sugar in separate sessions, using a within-subject design with conditions counterbalanced determined by a Latin square. In each session, smokers will be asked to smoke a cigarette in a standardized manner (10 puffs,30 second interval between puffs) and 1 hour later, ad libitum. Each of the sessions will be separated by at least 48 hours but not more than 5 days.
Treatment:
Other: Cigarettes with added sucrose

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Hanna Vanderloo, RN, MSN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems